Close

Lack of affordable basic medicine is leading to thousands of preventable deaths in childbirth

New research shows that 10,000 women could be saved each year with access to tranexamic acid (TXA) during childbirth
Woman holding a baby in a school setting

10,000 women could be saved every year if they had access to and were given the drug tranexamic acid (TXA) during childbirth, new research published in The Lancet Global Health shows.

However, TXA – a commonly used drug to reduce bleeding – is not affordable in the settings where it could have the greatest impact, raising serious questions about how it can be financed and used cost-effectively. Indeed, the study shows that TXA is unaffordable in 40% of countries that would see its benefit. 

Read the full story on The Blood Trials website.

Study at LSHTM

If you enjoyed this article and would like to build a career in global health, we offer a range of MSc programmes covering health and data, infectious and tropical diseases, population health, and public health and policy

Available on campus or online, including flexible study that works around your work and home life, be part of a global community at the UK's no.1 public health university.